WALTERS GROUP purchased 32.1% of their position (4.33M shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $15.17M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/19/2026ACC: 0001213900-26-091823
10% Owner
Since Dec 2025
+4.33M
Net shares
Net buyer
$15.17M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.33M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.33M
Price / share
$3.50
Trade value
$15.17M
% of position
32.1%
8/14/2026
13.51M→17.84M
Total
Net shares
+4.33M
Net value
$15.17M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2026 | P · Purchase | +4.33M | $3.50 | $15.17M | 32.1% | 13.51M | 17.84M |
| Total | +4.33M | $15.17M | ||||||
Derivative Transactions0
No derivative transactions reported